These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19022151)

  • 21. Imaging findings in bisphosphonate-related osteonecrosis of jaws.
    Arce K; Assael LA; Weissman JL; Markiewicz MR
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):75-84. PubMed ID: 19371818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 25. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
    Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.
    Omarini C; Filieri ME; Depenni R; Grizzi G; Cascinu S; Piacentini F
    Breast J; 2017 Sep; 23(5):610-611. PubMed ID: 28328105
    [No Abstract]   [Full Text] [Related]  

  • 27. Bisphosphonate-related osteonecrosis of the jaw: model and diagnosis with cone beam computerized tomography.
    Barragan-Adjemian C; Lausten L; Ang DB; Johnson M; Katz J; Bonewald LF
    Cells Tissues Organs; 2009; 189(1-4):284-8. PubMed ID: 18703870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
    Assael LA
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488
    [No Abstract]   [Full Text] [Related]  

  • 29. Bisphosphonate associated osteonecrosis of the jaw; similarities and differences in oncologic and non-oncologic patients.
    Chogle AR
    J Assoc Physicians India; 2011 Aug; 59():477-8. PubMed ID: 21887901
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 32. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kyrgidis A; Vahtsevanos K
    J Craniomaxillofac Surg; 2011 Jun; 39(4):271. PubMed ID: 20434920
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer].
    Iimura Y; Kaneko H; Hasegawa N; Takahashi Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1791-3. PubMed ID: 20841949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates and bisphosphonate induced osteonecrosis.
    Sawatari Y; Marx RE
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):487-98, v-vi. PubMed ID: 18088900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
    Wilde F; Steinhoff K; Frerich B; Schulz T; Winter K; Hemprich A; Sabri O; Kluge R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):412-9. PubMed ID: 19121962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A; Terpos E; Dimopoulos MA
    Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
    [No Abstract]   [Full Text] [Related]  

  • 38. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.
    McMahon RE; Bouquot JE; Glueck CJ; Griep JA; Adams WR; Spolnik KJ; Deardorf KA
    J Oral Maxillofac Surg; 2007 Sep; 65(9):1899-900. PubMed ID: 17719423
    [No Abstract]   [Full Text] [Related]  

  • 39. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.